NSE filing, NSE: IXIGO. Summary written from the filing by ALFA Finder's alert engine.
LE Travenues Technology Ltd: key numbers
- Share price
- ₹139.88
- Market cap
- ₹6,172 Cr
- Revenue (annual)
- ₹1,228 Cr
- Net profit (annual)
- ₹72.13 Cr
- P/E (TTM)
- 41.2×Sector 34.1×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 56.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from LE Travenues Technology Ltd
All →LE Travenues Technology Earnings Call Transcript: Key Takeaways
Ixigo delivered record PAT of ₹63.4 Cr, inflated by a ₹40.66 Cr one-time gain from Freshbus stake sale.
LE Travenues Technology Results Update
ixigo reported Q2 FY27 revenue of Rs. 320.96 crore and a record profit after tax of Rs. 63.42 crore, driven by strong growth in its hotel business.
LE Travenues Technology Investor Presentation: Key Takeaways
Ixigo delivered strong Q2 FY27 results with 13% YoY revenue growth and 22% GTV growth. The company reported record PAT, driven by core growth and a partial stake sale in Freshbus.
LE Travenues Technology Other Announcement
The company has re-appointed PricewaterhouseCoopers Services LLP as its Internal Auditor for a term of 12 months. This is a routine corporate governance disclosure.
LE Travenues Technology Management Change
Le Travenues Technology Limited has re-appointed PricewaterhouseCoopers Services LLP as the Internal Auditor of the Company for a term of 12 months.
- Execution
- 12 months
LE Travenues Technology Employee Stock Options
Le Travenues Technology allotted 173,780 equity shares upon the exercise of employee stock options. This issuance increases the company's paid-up share capital.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date